Micardis vs. Lipitor: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Micardis and Lipitor. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 613,432 people who take Micardis and Lipitor, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Lipitor?
Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.
613,432 people who take Micardis and Lipitor are studied.
Drugs being compared in this study:
- Lipitor (atorvastatin calcium)
- Micardis (telmisartan)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Micardis:
- not at all: 1.46 %
- somewhat: 11.1 %
- moderate: 34.98 %
- high: 40.7 %
- very high: 11.77 %
Lipitor:
- not at all: 1.4100000000000001 %
- somewhat: 10.46 %
- moderate: 30.71 %
- high: 41.74 %
- very high: 15.69 %
Want to compare Micardis with Lipitor?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on telmisartan and atorvastatin calcium (the active ingredients of Micardis and Lipitor, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lansoprazole and Trelegy Ellipta - 3 seconds ago
- Could Voriconazole cause Photopsia? - 13 seconds ago
- Could Lisinopril cause Iron Deficiency Anaemia? - 14 seconds ago
- Could Glucophage cause Type 2 Diabetes? - 18 seconds ago
- Could Glucophage cause Diabetes Mellitus Non-Insulin-Dependent? - 18 seconds ago
- Could Aventyl cause Urinary Tract Infection? - 21 seconds ago
- Could Novolog cause Personality Change? - 32 seconds ago
- Drug interactions of Aminophylline and Theo-Dur - 33 seconds ago
- Could Tamsulosin cause Joint Stiffness? - 39 seconds ago
- Could Montelukast Sodium cause Left Ventricular Hypertrophy? - 39 seconds ago